Estrogenic and antiestrogenic regulation of the half-life of covalently labeled estrogen receptor in MCF-7 breast cancer cells

Journal of Steroid Biochemistry and Molecular Biology

Volumn 57, Issue 3-4, 1996, Pages 203-213

  Borräs, Manuel ^a   Laios, Ioanna ^a   El Khissiin, Abdelhamid ^a   Seo, Hye Sook ^a   Lempereur, France ^a   Legros, Nicole ^a   Leclercq, Guy ^a  

^a JULES BORDET INSTITUTE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

MINK CELL FOCUS-FORMING VIRUS;

4 HYDROXYTAMOXIFEN; 4,4' ISOPROPYLIDENEDIPHENOL; DIETHYLSTILBESTROL; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; ESTRONE; IODINE 125; N BUTYL 11 (3,17BETA DIHYDROXYESTRA 1,3,5(10) TRIEN 7ALPHA YL) N METHYLUNDECANAMIDE; RALOXIFENE; RU 39 411; RU 58 668; TAMOXIFEN AZIRIDINE; TRITIUM; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CELL LINE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; ISOTOPE LABELING; RECEPTOR DENSITY; RECEPTOR DOWN REGULATION;

BREAST NEOPLASMS; CELL NUCLEUS; CYCLOHEXIMIDE; CYTOSOL; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGENS; HALF-LIFE; HUMANS; INDICATORS AND REAGENTS; MOLECULAR WEIGHT; PROTEIN SYNTHESIS INHIBITORS; PUROMYCIN; RECEPTORS, ESTROGEN; RNA, MESSENGER; TAMOXIFEN; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0029938824     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-0760(95)00272-3     Document Type: Article

References (63)

1. DeSombre E. R., Greene G. L. and Jensen E. V.: Estrogen receptors and the hormone dependence of breast cancer. In Breast Cancer: New Concepts in Etiology and Control (Edited by M. J. Brennan, C. M. McGrath and M. A. Rich). Liss, New York (1980) pp. 69-87.
2. Edwards D. P., Chamness G. C. and McGuire W. L.: Estrogen and progesterone receptors in breast cancer. Biochim. Biophys. Acta 560 (1979) 457-486.
3. Leclercq G. and Heuson J. C.: Therapeutic significance of sex steroid hormone receptors in the treatment of breast cancer. Eur. J. Cancer 13 (1977) 1205-1215.
4. Eckert R. L., Mullick A., Rorke E. A. and Katzenellenbogen B. S.: Estrogen receptor synthesis and turnover in MCF-7 breast cancer cells measured by a density shift technique. Endocrinology 144 (1984) 629-637.
5. Scholl S. and Lippman M. E.: The estrogen receptor in MCF-7 cells: evidence from dense amino acid labeling for rapid turnover and a dimeric model of activated nuclear receptor. Endocrinology 115, (1984) 1295.
6. Welshons W. V., Grady L. H., Judy B. M., Jordan V. C. and Preziosi D. A.: Subcellular compartmentalization of MCF-7 estrogen receptor synthesis and degradation. Molec. Cell. Endocr. 94 (1993) 183-194.
7. Lippman M. E., Bolan G. and Huff K.: The effects of estrogen and antiestrogen on hormone-responsive human breast cancer in long-term tissue culture. Cancer Res. 36 (1976) 4595-4601.
8. Darbre P., Yates J., Curtis S. and King R. J. B.: Effect of estradiol on human breast cancer cells in culture. Cancer Res. 43 (1983) 349-354.
9. Kasid A., Strobl J. S., Huff K., Greene G. L. and Lippman M. E.: A novel nuclear form of estradiol receptor in MCF-7 human breast cancer cells. Science 225 (1984) 1162-1165.
10. Jakesz R., Smith C. A., Aitken S., Huff K., Shuette W., Shackney S. and Lippman M. E.: Influence of cell proliferation and cell cycle phase on expression of estrogen receptor in MCF-7 breast cancer cells. Cancer Res. 44 (1984) 619-625.
11. Guilbaud N., Pichon M. F, Faye J. C, Bayard F. and Valette A.: Modulation of estrogen receptors by phorbol diesters in human breast MCF-7 cell line. Molec. Endocr. 56 (1988) 157-163.
12. Guilbaud N., Gas N., Dupont M. A. and Valette A.: Effects of differentiation-inducing agents on maturation of human MCF-7 breast cancer cells. J. Cell. Physiol. 145 (1990) 162-172.
13. Bezwoda W. R. and Meyer K.: Effect of α-Interferon, 17β-estradiol, and tamoxifen on estrogen receptor concentration and cell cycle kinetics of MCF-7 cells. Cancer Res. 50 (1990) 5387-5391.
14. Danforth D. N. and Sgagias M. K.: Tumor necrosis factor-α modulates oestradiol responsiveness of MCF-7 breast cancer cells in vitro. J. Endocr. 138 (1993) 517-528.
15. Gyling M. and Leclercq G.: Estrogenic and antiestrogenic down-regulation of estrogen receptor levels: evidence for two different mechanisms. J. Recept. Res. 10 (1988) 217-234.
16. Horwitz K. B. and McGuire W. L.: Nuclear mechanisms of estrogen action. Effects of estradiol and anti-estrogens on estrogen receptors and nuclear receptor processing. J. Biol. Chem. 253 (1978) 8185-8191.
17. Horwitz K. B. and McGuire W. L.: Estrogen control of progesterone receptor in human breast cancer. Correlation with nuclear processing of estrogen receptor. J. Biol. Chem. 253 (1978) 2223-2228.
18. Strobl J. S., Kassid A., Huff K. K. and Lippman M. E.: Kinetic alterations in estrogen receptors associated with estrogen receptor processing in human breast cancer cells. Endocrinology 115 (1984) 1116-1124.
19. Borras M., Hardy L., Lempereur F., El Khissiin A. H., Legros N., Gol-Winkler R. and Leclercq G.: Estradiol-induced down-regulation of estrogen receptor. Effect of various modulators of protein synthesis and expression. J. Steroid Biochem. Molec. Biol. 48 (1994) 325-336.
20. Berthois Y., Dong X. F., Roux-Dosseto M. and Martin P. M.: Expression of estrogen receptor and its messenger ribonucleic acid in MCF-7 cell line; multiparametric analysis of its processing and regulation by estrogen. Molec. Cell. Endocr. 74 (1990) 11-20.
21. Saceda M., Lippman M. P., Chambon P., Lindsey R. L., Ponglikitmogkol M., Puente M. and Martin M. B.: Regulation of the estrogen receptor in MCF-7 cells by estradiol. Molec. Endocr. 2 (1988) 1157-1162.
22. Read L. D., Greene G. L. and Katzenellenbogen B. S.: Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonist and growth factors. Molec. Endocr. 3 (1989) 295-304.
23. Berkenstam A., Glaumann H., Martin M., Gustafsson J. A. and Norstedt G.: Hormonal regulation of estrogen receptor messenger ribonucleic acid in T47D and MCF-7 breast cancer cells. Molec. Endocr. 3 (1989) 22-28.
24. Maxwell B. L., McDonell D. P., Conneely O. M., Shulz T. Z., Greene G. L. and O'Malley B.: Structural organization and regulation of the chicken estrogen receptor. Molec. Endocr. 1 (1987) 25-34.
25. Nardulli A. M. and Katzenellenbogen B. S.: Dynamics of estrogen receptor turnover in uterine cells in vitro and uteri in vivo. Endocrinology 199 (1986) 2038-2046.
26. Pakdel F., Le Goff P. and Katzenellenbogen B. S.: An assessment of the role of domain F and PEST sequences in estrogen receptor half-life and bioactivity. J. Steroid Biochem. Molec. Biol. 46 (1993) 663-672.
27. Kaneko K. J., Furlow J. D. and Gorski J.: Involvement of the coding sequence for the estrogen receptor gene in autologous ligand-dependent down-regulation. Molec. Endocr. 7 (1993) 879-888.
28. Bellingham D. L., Dar M. and Cidlowski J. A.: Ligand-dependent down-regulation of stably transfected human glucocorticoid receptors is associated with the loss of functional glucocorticoid responsiveness. Molec. Endocr. 6 (1992) 2090-2102.
29. Read L. D., Snider C. E., Miller G. L. and Katzenellenbogen B. S.: Ligand-modulated regulation of progesterone receptor messenger ribonucleic acid and protein in human breast cancer cell lines. Molec. Endocr. 2 (1988) 263-271.
30. Wolf D. A., Herzingert T., Hermeking H., Blaschke D. and Horz W.: Transcriptional and posttranscriptional regulation of human androgen receptor expression by androgen. Molec. Endocr. 7 (1993) 924-936.
31. Kiang D. T., Kollander R. E., Thomas T. and Kennedy B.: Up-regulation of estrogen receptors by nonsteroidal antiestrogens in human breast cancer. Cancer Res. 49 (1989) 5312-5316.
32. Leclercq G., Legros N. and Piccart M. J.: Accumulation of a non-binding form of estrogen receptor in MCF-7 cells under hydroxytamoxifen treatment. J. Steroid Biochem. Molec. Biol. 41 (1992) 545-552.
33. Reese J. C. and Katzenellenbogen B. S.: Examination of the DNA-binding ability of estrogen receptor in whole cells: implications for hormone-independent transactivation and the actions of antiestrogens. Molec. Cell. Biol. 12 (1992) 4531-4538.
34. Jin L., Borras M., Lacroix M., Legros N. and Leclercq G.: Antiestrogenic activity of two 11β-estradiol derivatives on MCF-7 breast cancer cells. Steroids 60 (1995) 512-518.
35. Parczyk K., Madino R., Angerer E. V. and Schneider M. R.: Various pure antiestrogens downregulate the ER while partial agonists do not. J. Steroid Biochem. Molec. Biol. (1996) In press.
36. Dauvois S., Danielian P. S., White R. and Parker M. G.: Antiestrogen ICI 164,384 reduces cellular estrogen receptor content by increasing its turnover. Proc. Natn. Acad. Sci. U.S.A. 89 (1990) 4037-4041.
37. Gibson M. K., Nemmers L. A., Beckman W. C., Davis L. V., Curtis S. W. and Korach K. S.: The mechanism of ICI 164,384 antiestrogenicity involves rapid loss of estrogen receptor in uterine tissue. Endocrinology 129 (1991) 2000-2010.
38. Dauvois S., White R. and Parker M. G.: The antiestrogen ICI 182780 disrupts estrogen receptor nucleocytoplasmic shuttling. J. Cell. Sci. 106 (1993) 1377-1388.
39. Saceda M., Lippman M. E., Chambon P., Lindsey R. L., Puente M. and Martin M. B.: Role of an estrogen receptor-dependent mechanism in the regulation of estrogen receptor mRNA in MCF-7 cells. Molec. Endocr. 3 (1989) 1782-1787.
40. Robertson D. W., Wei L. L., Haves J. R., Carlson K. E., Katzenellenbogen J. A. and Katzenellenbogen B. S.: Tamoxifen aziridines: effective inactivators of the estrogen receptor. Endocrinology 109 (1981) 1298-1300.
41. 3H]-tamoxifen aziridine. J. Biol. Chem. 258 (1983) 3487-3495.
42. Piccart M. J., Muquardt C., Bosman C., Pirotte P., Veenstra S., Grillo F. and Leclercq G.: Comparison of tritiated estradiol and tamoxifen aziridine for measurement of estrogen receptors in human breast cancer cytosols. J. Natn. Cancer Inst. 83 (1991) 1553-1559.
43. Olea-Serrano N., Devleeschouwer N., Leclercq G. and Heuson J. C.: Assay for estrogen and progesterone receptors of breast cancer cell lines in monolayer culture. Eur. J. Cancer Clin. Oncol. 21 (1985) 965-973.
44. Scatchard G.: The attraction of proteins for small molecules and ions. Ann. N.Y. Acad. Sci. 51 (1949) 660-672.
45. Stoessel S. and Leclercq G.: Competitive binding assay for estrogen receptor in monolayer culture: measure of receptor activation potency. J. Steroid Biochem. 25 (1986) 677-682.
46. EORTC Breast Cancer Coorperative Group.: Revision of the standard for the assessment of hormone receptors in human breast cancer. Eur. J. Cancer 16 (1980) 1513-1515.
47. Monsma F. J., Katzenellenbogen B. S., Miller M. A., Ziegler Y. S. and Katzenellenbogen J. A.: Characterization of the estrogen receptor and its dynamics in MCF-7 human breast cancer cells using covalently attaching antiestrogen. Endocrinology 115 (1984) 143-153.
48. Gyling M. and Leclercq G.: Estrogen and antiestrogen interaction with estrogen receptor of MCF-7 cells. Relationship between processing and estrogenicity. J. Steroid Biochem. 29 (1988) 1-8.
49. Zhou Y., Chorich L. P., Mahesh V. B. and Ogle T. F.: Regulation of estrogen receptor protein and messenger ribonucleic acid by estradiol and progesterone in rat uterus. J. Steroid Biochem. Molec. Biol. 46 (1993) 687-698.
50. Cho H., Peters A. N. G. and Katzenellenbogen B. S.: Differential regulation of gene expression by estrogen in estrogen-independent and -dependent MCF-7 human breast cancer cell sublines. Molec. Endocr. 3 (1991) 1323-1330.
51. Fawell S. E., While R., Hoare S., Sydenham M., Page M. and Parker M. G.: Inhibition of estrogen receptor-DNA binding by the "pure" antiestrogen ICI 164,384 appears to be mediated by impaired receptor dimerization. Proc. Natn. Acad. Sci. U.S.A. 87 (1990) 6883-6887.
52. Horwitz K. B. and McGuire W. L.: Nuclear estrogen receptors. Effect of inhibitors on processing and steady state levels. J. Biol. Chem. 255 (1980) 9699-9705.
53. Reick M., Robertson R. W., Pasco D. S. and Fagan J. B.: Down-regulation of nuclear aryl hydrocarbon receptor DNA-binding and transactivation functions: requirement for a labile or inducible factor. Molec. Cell. Biol. 14 (1994) 5653-5660.
54. Hoffman E. C., Reyes H., Chu F. F., Sander F., Conley L. H., Borrks B. A. and Hankinson O.: Cloning of a factor required for activity of the Ah (dioxin) receptor. Science 252 (1991) 954-958.
55. Dolwick K. M., Swanson H. I. and Bradfield C. A.: In vitro analysis of Ah receptor domains involved in ligand-activated DNA recognition. Proc. Natn. Acad. Sci. U.S.A. 90 (1993) 8566-8570.
56. Ree A. H., Landmark B. F., Walaas H., Lahooti H., Eikvar L., Eskild W. and Hansson V.: Down-regulation of messenger ribonucleic acid and protein levels for estrogen receptors by phorbol ester and calcium in MCF-7 cells. Endocrinology 129 (1991) 339-344.
57. Borrâs M. and Leclercq G.: Modulatory effect of nonesterified fatty acids on structure and binding characteristics of estrogen receptor from MCF-7 human breast cancer cells. J. Receptor Res. 12 (1992) 463-484.
58. Mitsuhashi N., Mizuno M., Miyagawa A. and Kato J.: Effect of phosphatidyl inositol on progesterone receptors in rat uterine cytosol. Endocr. Jpn. 35 (1988) 131-134.
59. Tsai M. J. and O'Malley B. W.: Molecular mechanisms of action of steroid/thyroid receptor superfamily members. A. Rev. Biochem. 63 (1994) 451-486.
60. Arnold S. F., Obourn J. D., Yudt M. R., Carter T. H. and Notides A. C.: In vivo and in vitro phosphorylation of the human estrogen receptor. J. Steroid Biochem. Molec. Biol. 52 (1995) 159-171.
61. Orti E., Mendel D. B., Smith L. I. and Munck A.: Agonist-dependent phosphorylation and nuclear dephosphorylation of glucocorticoid receptors in intact cells. J. Biol. Chem. 264 (1989) 9728-9731.
62. Orti E., Hu L. M. and Munck A.: Kinetics of glucocorticoid receptor hyperphosphorylation in intact cells. J. Biol. Chem. 268 (1993) 7779-7784.
63. Molinari A. M., Abbondanza C., Armetta I., Medici N., Minucci S., Montcharmont B., Nigro V. and Puca G. A.: Proteolytic activity of the purified hormone-binding subunit in the estrogen receptor. Proc. Natn. Acad. Sci. U.S.A. 88 (1991) 4463 4467.